October 2020: Astellas Pharma Inc. and Iota Biosciences, Inc. announced a merger agreement, following which, Astellas will acquire Iota’s unique bioelectronics technology.
July 2019: BioTelemetry acquired ADEA Medical AB, a Swedish medical technology company that provides healthcare services and diagnostic products. This acquisition will expand the portfolio of BioTelemetry to diagnostic products.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3918
Published Date: Aug 08, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing prevalence of asthma, backed by rapid urbanization is estimated to boost market growth.
The market is anticipated to attain a CAGR of 25% over the forecast period, i.e., 2023 – 2035.
The major players in the market are Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, Health Care Originals Inc, and others.
The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.